Overview

Early Levothyroxine Post Radioactive Iodine

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The study will try to answer the question of whether early treatment with levothyroxine at 4 weeks after radioactive iodine for Graves'disease will prevent overt hypothyroidism (low thyroid hormone levels).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Hormones
Iodine